selected publications
-
Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group.
Annals of the rheumatic diseases.
2024
Information Resource
GET IT
Times cited: 36 -
Advances in the treatment of polymyalgia rheumatica and giant cell arteritis.
Nature reviews. Rheumatology.
2024
Information Resource
GET IT
Times cited: 1 -
Prevalence of frailty in patients with polymyalgia rheumatica and association with health-related quality of life, cognition and sarcopenia.
Rheumatology (Oxford, England).
2022
Academic Article
GET IT
Times cited: 20 -
Outcomes of COVID-19 and Factors Associated With Its Severity Among Hospitalized Patients With and Without Systemic Rheumatic Disease During the First Wave of the Pandemic in New York City.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
2022
Academic Article
GET IT
Times cited: 1 - Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City. Clinical rheumatology. 2022 Article GET IT
-
Rho Kinase Expression in Giant Cell Arteritis: Validating Phosphorylated Ezrin/Radixin/Moesin Intensity Score to Increase Sensitivity of Temporal Artery Biopsy.
The Journal of rheumatology.
2022
Academic Article
GET IT
Times cited: 1 -
Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study.
American journal of human genetics.
2020
Information Resource
GET IT
Times cited: 59 -
Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on Treatment.
Current allergy and asthma reports.
2020
Information Resource
GET IT
Times cited: 15 -
Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
Best practice & research. Clinical rheumatology.
2019
Information Resource
GET IT
Times cited: 4 -
Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica.
Arthritis & rheumatology (Hoboken, N.J.).
2016
Academic Article
GET IT
Times cited: 102 -
B-cell-targeted therapy in systemic vasculitis.
Current opinion in rheumatology.
2016
Information Resource
GET IT
Times cited: 11 -
Pregnancy Does Not Adversely Affect Postoperative Pain and Function in Women With Total Hip Arthroplasty.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
2015
Article
GET IT
Times cited: 6 -
Pulmonary vasculitis.
Rheumatic diseases clinics of North America.
2015
Information Resource
GET IT
Times cited: 36 -
Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Rheumatic diseases clinics of North America.
2015
Information Resource
GET IT
Times cited: 26 -
Vasculitis in antiphospholipid syndrome.
Rheumatic diseases clinics of North America.
2015
Information Resource
GET IT
Times cited: 39 -
Current therapies for ANCA-associated vasculitis.
Annual review of medicine.
2014
Information Resource
GET IT
Times cited: 20 -
Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis.
Rheumatology (Oxford, England).
2014
Academic Article
GET IT
Times cited: 15 -
Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis (Wegener's).
Arthritis care & research.
2014
Academic Article
GET IT
Times cited: 31 -
Lepromatous leprosy mimicking systemic lupus erythematosus: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery.
2014
Academic Article
GET IT
Times cited: 15 -
Biomarkers in ANCA-associated vasculitis.
Current rheumatology reports.
2013
Information Resource
GET IT
Times cited: 11